R21 CA201757/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Your saved search

Your RSS Feed

Year	Number of Results
2017	1
2019	1
2021	1
2022	1
2025	0

Page 1

Loss of p16^INK4A stimulates aberrant mitochondrial biogenesis through a CDK4/Rb-independent pathway.

Tyagi E, Liu B, Li C, Liu T, Rutter J, Grossman D. Tyagi E, et al. Oncotarget. 2017 Aug 3;8(34):55848-55862. doi: 10.18632/oncotarget.19862. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915557 Free PMC article.

Targeting Fc Receptor-Mediated Effects and the "Don't Eat Me" Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer.

Tian L, Xu B, Teng KY, Song M, Zhu Z, Chen Y, Wang J, Zhang J, Feng M, Kaur B, Rodriguez L, Caligiuri MA, Yu J. Tian L, et al. Clin Cancer Res. 2022 Jan 1;28(1):201-214. doi: 10.1158/1078-0432.CCR-21-1248. Epub 2021 Oct 13. Clin Cancer Res. 2022. PMID: 34645647 Free PMC article.

A novel CDKN2A variant (p16^L117P ) in a patient with familial and multiple primary melanomas.

Li C, Liu T, Liu B, Hernandez R, Facelli JC, Grossman D. Li C, et al. Pigment Cell Melanoma Res. 2019 Sep;32(5):734-738. doi: 10.1111/pcmr.12787. Epub 2019 May 3. Pigment Cell Melanoma Res. 2019. PMID: 31001908 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year